The Patent Finder

Argos Therapeutics, Inc.

Also on record
Records under this name other than patents Argos Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Argos Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,893,200Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,040,303Apparatus for measuring volume of a fluid
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,030,080Systems and methods for processing samples in a closed container, and related devices
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,085,807Strain-independent amplification of pathogens and vaccines thereto
Formerly held
Term ended
Term ended Oct 14, 2026 · USPTO record
Term endedTerm ended Oct 14, 2026USPTO record
US 10,022,731Centrifuge Vessels with a Center Mound and an Internal Elongate Tube Suitable for Live Cell Processing and Associated Systems and Methods
Formerly held
Lapsed on the fee record
Ended Jul 17, 2026 · High confidence
Lapsed on the fee recordEnded Jul 17, 2026High confidence
US 9,970,068Primers and probes for the amplification and detection of HIV GAG, REV and NEF polynucleotides
Formerly held
Lapsed on the fee record
Ended May 15, 2026 · USPTO record
Lapsed on the fee recordEnded May 15, 2026USPTO record
US 9,102,726Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same
Formerly held
Term ended
Term ended Mar 27, 2026 · USPTO record
Term endedTerm ended Mar 27, 2026USPTO record
US 8,672,879Devices, systems and related methods suitable for delivery of a liquid medicament stored at cryogenic temperatures
Formerly held
Lapsed on the fee record
Ended Mar 18, 2026 · USPTO record
Lapsed on the fee recordEnded Mar 18, 2026USPTO record
US 8,658,771Humanized Antibodies Against Human Interferon-Alpha
Formerly held
Lapsed on the fee record
Ended Feb 25, 2026 · Medium confidence
Lapsed on the fee recordEnded Feb 25, 2026Medium confidence
US 11,248,209Mature Dendritic Cell Compositions and Methods for Culturing Same
Formerly held
Lapsed on the fee record
Ended Feb 15, 2026 · High confidence
Lapsed on the fee recordEnded Feb 15, 2026High confidence
10 of 46 patents shown.
Pro members see all 46.
Pro members: see all 46 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited